港股异动 | 医药股再度走强上半年药企业绩整体表现稳健机构看好创新药长期向好逻辑

智通财经2025-09-01

【港股异动 | 医药股再度走强上半年药企业绩整体表现稳健机构看好创新药长期向好逻辑】智通财经APP获悉，医药股今日再度走强，截至发稿，加科思-B(01167.HK)涨23.18%，报9.99港元；三叶草生物-B(02197.HK)涨22.09%，报1.05港元；映恩生物-B(09606.HK)涨10.84%，报349.8港元；药明生物(02269.HK)涨7.53%，报35.7港元；药明康德(...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2564089620?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-01 14:15","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2564089620","market":"hk","top_or_hot":-1,"title":"港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑","media":"智通财经","content":"<div>\n<p>【港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑】智通财经APP获悉，医药股今日再度走强，截至发稿，加科思-B(01167.HK)涨23.18%，报9.99港元；三叶草生物-B(02197.HK)涨22.09%，报1.05港元；映恩生物-B(09606.HK)涨10.84%，报349.8港元；药明生物(02269.HK)涨7.53%，报35.7港元；药明康德(...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-01 14:15 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=ganggu><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑】智通财经APP获悉，医药股今日再度走强，截至发稿，加科思-B(01167.HK)涨23.18%，报9.99港元；三叶草生物-B(02197.HK)涨22.09%，报1.05港元；映恩生物-B(09606.HK)涨10.84%，报349.8港元；药明生物(02269.HK)涨7.53%，报35.7港元；药明康德(...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603259","symbol_name":"药明康德","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2564089620","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564089620","pubTimestamp":1756707302,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑】智通财经APP获悉，医药股今日再度走强，截至发稿，加科思-B(01167.HK)涨23.18%，报9.99港元；","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","159992":"创新药","603259":"药明康德","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","SG9999002463.SGD":"LionGlobal China Growth SGD","LU1720050803.USD":"安联全方位中国股票基金","09606":"映恩生物-B","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU1997245177.USD":"安联神洲A股基金","BK1574":"生物医药B类股","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","BK1521":"挪威政府全球养老基金持仓","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1046422090.SGD":"Fidelity Pacific A-SGD","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","02197":"三叶草生物-B","06978":"永泰生物-B","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","BK1589":"北水核心资产","02359":"药明康德","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","02269":"药明生物","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","01167":"加科思-B","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","09939":"开拓药业-B","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元"},"translate_title":"Changes in Hong Kong stocks | Pharmaceutical stocks strengthened again. The overall performance of pharmaceutical companies in the first half of the year was stable. Institutions are optimistic about the long-term positive logic of innovative drugs","themeId":"9e120cbc689472c9ad07159548b432a1","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"159992":1,"603259":1,"09939":1,"01167":1,"02197":1,"02359":1,"06978":1,"02269":1,"09606":1},"content_text":"【港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑】智通财经APP获悉，医药股今日再度走强，截至发稿，加科思-B(01167.HK)涨23.18%，报9.99港元；三叶草生物-B(02197.HK)涨22.09%，报1.05港元；映恩生物-B(09606.HK)涨10.84%，报349.8港元；药明生物(02269.HK)涨7.53%，报35.7港元；药明康德(02359.HK)涨6.95%，报115.4港元。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2564089620","isCrawlerRequest":true}

港股异动 | 医药股再度走强 上半年药企业绩整体表现稳健 机构看好创新药长期向好逻辑

精彩评论

港股异动 | 医药股再度走强上半年药企业绩整体表现稳健机构看好创新药长期向好逻辑